Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 1/2021

26.11.2020 | Clinical Investigation

Comparative study of topical regimen for adenoviral kearoconjunctivitis by 0.1% fluorometholone with and without polyvinyl alcohol iodine

verfasst von: Kazuki Matsuura, Yuki Terasaka, Dai Miyazaki, Yumiko Shimizu, Yoshitsugu Inoue

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to compare the efficacy of the topical regimens of iodine/steroids vs. antibiotics/steroids in acute to subacute adenoviral keratoconjunctivitis.

Study design

A prospective open-label study.

Patients and methods

Nineteen patients diagnosed with unilateral or bilateral adenoviral conjunctivitis at less than 1 week from onset were enrolled in this study. Patients were divided randomly into two groups; group 1 was treated with 1.5% levofloxacin with 0.1% fluorometholone administered four times a day and group 2 was treated with a sixfold dilution of polyvinyl alcohol iodine (PAI) solution with 0.1% fluorometholone four times a day. Conjunctival samples from all affected eyes were obtained for real-time PCR. The total scores of acute signs (i.e., eyelid edema, conjunctival injecton, conjunctival discharge, follicules, pseudomembranes, subconjunctival hemorrhage) and symptoms, HAdV DNA copy number, and the presence of multiple subepithelial corneal infiltrates (MSI) were evaluated every 5 visits up to Day 30 after diagnosis.

Results

Comparing the total scores of acute signs and symptoms and viral load, we observed no significant differences between the two groups. At day 15 after diagnosis the proportion of patients with MSI in group 2 (35.7%) was significantly lower than in group 1 (0%).

Conclusions

The impact of topical iodine/steroid therapy on acute signs and symptoms associated with adenoviral conjunctivitis is limited and not substantially different in the responses to antibiotics/steroids. However, this regimen results in a significant decrease in the incidence of MSI during the subacute phase of infection.
Literatur
1.
Zurück zum Zitat Inoue K. Treatment of viral conjunctivitis. Nippon Ganka Gakkai Zasshi. 2003;107:24–6 ((in Japanese)).PubMed Inoue K. Treatment of viral conjunctivitis. Nippon Ganka Gakkai Zasshi. 2003;107:24–6 ((in Japanese)).PubMed
2.
Zurück zum Zitat Romanowski EG, Yates KA, Gordon YJ. Topical corticosteroids of limited potency promote adenovirus replication in the Ad5/NZW rabbit ocular model. Cornea. 2002;21:289–91.CrossRef Romanowski EG, Yates KA, Gordon YJ. Topical corticosteroids of limited potency promote adenovirus replication in the Ad5/NZW rabbit ocular model. Cornea. 2002;21:289–91.CrossRef
3.
Zurück zum Zitat Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology. 1997;195(Suppl 2):29–35.CrossRef Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology. 1997;195(Suppl 2):29–35.CrossRef
4.
Zurück zum Zitat Pepose JS, Ahuja A, Liu W, Narvekar A, Haque R. Randomized, controlled, phase 2 trial of povidone-iodine/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol. 2018;194:7–15.CrossRef Pepose JS, Ahuja A, Liu W, Narvekar A, Haque R. Randomized, controlled, phase 2 trial of povidone-iodine/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol. 2018;194:7–15.CrossRef
5.
Zurück zum Zitat Yazar H, Yarbag A, Balci M, Teker B, Tanyeri P. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis. J Pak Med Assoc. 2016;66:968–70.PubMed Yazar H, Yarbag A, Balci M, Teker B, Tanyeri P. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis. J Pak Med Assoc. 2016;66:968–70.PubMed
6.
Zurück zum Zitat Clement C, Capriotti JA, Kumar M, Hobden JA, Foster TP, Bhattacharjee PS, et al. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2011;52:339–44.CrossRef Clement C, Capriotti JA, Kumar M, Hobden JA, Foster TP, Bhattacharjee PS, et al. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2011;52:339–44.CrossRef
7.
Zurück zum Zitat Pelletier JS, Stewart K, Trattler W, Ritterband DC, Braverman S, Samson CM, et al. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther. 2009;26:776–83.CrossRef Pelletier JS, Stewart K, Trattler W, Ritterband DC, Braverman S, Samson CM, et al. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther. 2009;26:776–83.CrossRef
8.
Zurück zum Zitat Pinto RDP, Lira RPC, Abe RY, Zacchia RS, Felix JPF, Pereira AVF, et al. Dexamethasone/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial. Curr Eye Res. 2015;40:870–7.CrossRef Pinto RDP, Lira RPC, Abe RY, Zacchia RS, Felix JPF, Pereira AVF, et al. Dexamethasone/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial. Curr Eye Res. 2015;40:870–7.CrossRef
9.
Zurück zum Zitat Pepose JS, Narvekar A, Liu W, Haque R. A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis. Clin Ophthalmol. 2019;13:535–44.CrossRef Pepose JS, Narvekar A, Liu W, Haque R. A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis. Clin Ophthalmol. 2019;13:535–44.CrossRef
10.
Zurück zum Zitat Isenberg SJ, Apt L, Valenton M, Signore MD, Leo C, Labrador MA, et al. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol. 2002;134:681–8.CrossRef Isenberg SJ, Apt L, Valenton M, Signore MD, Leo C, Labrador MA, et al. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol. 2002;134:681–8.CrossRef
11.
Zurück zum Zitat Dosso AA, Rungger-Brabdle E. A Clinical course of epidemic keratoconjunctivitis: evaluation by in vivo confocal microscopy. Cornea. 2008;27:263–8.CrossRef Dosso AA, Rungger-Brabdle E. A Clinical course of epidemic keratoconjunctivitis: evaluation by in vivo confocal microscopy. Cornea. 2008;27:263–8.CrossRef
12.
Zurück zum Zitat Takeuchi S, Itoh N, Uchio E, Aoki K, Ohno S. Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol. 1999;37:1839–45.CrossRef Takeuchi S, Itoh N, Uchio E, Aoki K, Ohno S. Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol. 1999;37:1839–45.CrossRef
13.
Zurück zum Zitat Xu W, McDonough MC, Erdman DD. Species-specific identification of human adenoviruses by a multiplex PCR assay (published correction: J Clin Microbiol 2001 Apr; 39(4): 1686). J Clin Microbiol. 2000;38:4114–20.CrossRef Xu W, McDonough MC, Erdman DD. Species-specific identification of human adenoviruses by a multiplex PCR assay (published correction: J Clin Microbiol 2001 Apr; 39(4): 1686). J Clin Microbiol. 2000;38:4114–20.CrossRef
14.
Zurück zum Zitat Fujimoto T, Matsushima Y, Shimizu H, Ishimaru Y, Kano A, Nakajima E, et al. A molecular epidemiologic study of human adenovirus type 8 isolates causing epidemic keratoconjunctivitis in Kawasaki City, Japan in 2011. Jpn J Infect Dis. 2012;65:260–3.CrossRef Fujimoto T, Matsushima Y, Shimizu H, Ishimaru Y, Kano A, Nakajima E, et al. A molecular epidemiologic study of human adenovirus type 8 isolates causing epidemic keratoconjunctivitis in Kawasaki City, Japan in 2011. Jpn J Infect Dis. 2012;65:260–3.CrossRef
15.
Zurück zum Zitat Yates KA, Shanks RMQ, Kowalski RP, Romanowski EG. The in vitro evaluation of povidone-iodine against multiple ocular adenoviral types. J Ocul Pharmacol Ther. 2019;35:132–6.CrossRef Yates KA, Shanks RMQ, Kowalski RP, Romanowski EG. The in vitro evaluation of povidone-iodine against multiple ocular adenoviral types. J Ocul Pharmacol Ther. 2019;35:132–6.CrossRef
16.
Zurück zum Zitat Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H, et al. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol. 2017;95:e686–92.CrossRef Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, Sherbany H, et al. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol. 2017;95:e686–92.CrossRef
17.
Zurück zum Zitat Galasso GJ, et al. Antiviral drugs. In: Notkins A, et al., editors. Concepts in viral pathogenesis. New York: Spronger-Verlag; 1984. p. 382–8.CrossRef Galasso GJ, et al. Antiviral drugs. In: Notkins A, et al., editors. Concepts in viral pathogenesis. New York: Spronger-Verlag; 1984. p. 382–8.CrossRef
18.
Zurück zum Zitat Asena L, Şıngar Özdemir E, Burcu A, Ercan E, Çolak M, Altınörs DD. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis. Eye (Lond). 2017;31:781–7.CrossRef Asena L, Şıngar Özdemir E, Burcu A, Ercan E, Çolak M, Altınörs DD. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis. Eye (Lond). 2017;31:781–7.CrossRef
19.
Zurück zum Zitat Romanowski EG, Roba LA, Wiley L, Araullo-Cruz T, Gordon YJ. The effects of corticosteroids of adenoviral replication. Arch Ophthalmol. 1996;114:581–5.CrossRef Romanowski EG, Roba LA, Wiley L, Araullo-Cruz T, Gordon YJ. The effects of corticosteroids of adenoviral replication. Arch Ophthalmol. 1996;114:581–5.CrossRef
20.
Zurück zum Zitat Lund OE, Stefani FH. Corneal histology after epidemic keratoconjunctivitis. Arch Ophthalmol. 1978;96:2085–8.CrossRef Lund OE, Stefani FH. Corneal histology after epidemic keratoconjunctivitis. Arch Ophthalmol. 1978;96:2085–8.CrossRef
21.
Zurück zum Zitat Uemura T, Migita H, Ueno T, Saeki Y, Fujimoto T, et al. Clinical and virological analysis of epidemic keratoconjunctivitis caused by adenovirus type 54 in a regional ophthalmic clinic in Kyushu, Japan. Clin Ophthalmol. 2018;12:511–7.CrossRef Uemura T, Migita H, Ueno T, Saeki Y, Fujimoto T, et al. Clinical and virological analysis of epidemic keratoconjunctivitis caused by adenovirus type 54 in a regional ophthalmic clinic in Kyushu, Japan. Clin Ophthalmol. 2018;12:511–7.CrossRef
22.
Zurück zum Zitat Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982;15:635–9.CrossRef Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982;15:635–9.CrossRef
23.
Zurück zum Zitat Inoue Y, Usui M, Ohashi Y, Shiota H, Yamazaki T. Preoperative Disinfection Study Group. Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: a prospective randomized multicenter study. Jpn J Ophthalmol. 2008;52:151–61.CrossRef Inoue Y, Usui M, Ohashi Y, Shiota H, Yamazaki T. Preoperative Disinfection Study Group. Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: a prospective randomized multicenter study. Jpn J Ophthalmol. 2008;52:151–61.CrossRef
24.
Zurück zum Zitat Shibata Y, Yuta Tanaka Y, Tomita T, Taogoshi T, Kimura Y, Taiichiro Chikama T, et al. Evaluation of corneal damage caused by iodine preparations using human corneal epithelial cells. Jpn J Ophthalmol. 2014;58:522–7.CrossRef Shibata Y, Yuta Tanaka Y, Tomita T, Taogoshi T, Kimura Y, Taiichiro Chikama T, et al. Evaluation of corneal damage caused by iodine preparations using human corneal epithelial cells. Jpn J Ophthalmol. 2014;58:522–7.CrossRef
Metadaten
Titel
Comparative study of topical regimen for adenoviral kearoconjunctivitis by 0.1% fluorometholone with and without polyvinyl alcohol iodine
verfasst von
Kazuki Matsuura
Yuki Terasaka
Dai Miyazaki
Yumiko Shimizu
Yoshitsugu Inoue
Publikationsdatum
26.11.2020
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 1/2021
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-020-00788-3

Weitere Artikel der Ausgabe 1/2021

Japanese Journal of Ophthalmology 1/2021 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Open Access 22.02.2024 | Peeling | Originalien

Selektive Vitalfarbstoffe in der Makulachirurgie

Erhöhen sie die Wahrscheinlichkeit der intraoperativen ILM-Identifizierung auch bei einem erfahrenen Operateur?

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.